Literature DB >> 20924137

Effect of a porous tantalum rod on early and intermediate stages of necrosis of the femoral head.

Guohui Liu1, Jing Wang, Shuhua Yang, Weihua Xu, Shunan Ye, Tian Xia.   

Abstract

The aim of this study was to evaluate the effect of a porous tantalum rod implant for the treatment of early femoral head necrosis. From April 2007 to June 2009, a total of 35 femoral head necrosis patients (with 49 hips) were treated with core decompression in combination with the insertion of a porous tantalum rod. The mean age was 38.2 years (22-50 years) and the mean follow-up period was 15.2 months (12-36 months). The surgical time and blood loss were recorded. The Harris hip scores and radiological results were adopted for evaluation. The mean surgical time was 35 min, and the mean blood loss was 50 ml. The mean Harris score improved from 48.3 ± 3.2 preoperative to 83.7 ± 4.1 at the last follow-up (p < 0.05). Eight affected hips exhibited progressive pain including three hips that progressed to femoral collapse, and one revision followed by total hip arthroplasty (THA). For the patient who underwent revision and THA, the articular cartilage surface was seen to be damaged and fragmented. High-density metal particle residuals were observed on radiograph in the bone channel and femoral marrow cavity. We conclude that the selection criteria for porous tantalum implants should be early and intermediate stages of femoral head necrosis. Further study is warranted to reveal whether the metal particles released play a role in the progression of pain and failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924137     DOI: 10.1088/1748-6041/5/6/065003

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  16 in total

1.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 2.  Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis : A systematic review and meta-analysis.

Authors:  Wei Li; Ziliang Ye; Wei Wang; Kun Wang; Lang Li; Dewei Zhao
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

3.  Preparation of a novel composite nanofiber gel-encapsulated human placental extract through layer-by-layer self-assembly.

Authors:  Guohui Liu; X I Chen; W U Zhou; Shuhua Yang; Shunan Ye; Faqi Cao; Y I Liu; Yuan Xiong
Journal:  Exp Ther Med       Date:  2016-02-17       Impact factor: 2.447

4.  Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial.

Authors:  Qiang Mao; Weidong Wang; Taotao Xu; Shanxing Zhang; Luwei Xiao; Di Chen; Hongting Jin; Peijian Tong
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

5.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

6.  Cell therapy for osteonecrosis of femoral head and joint preservation.

Authors:  You Seung Chun; Dong Hwan Lee; Tae Gu Won; Chan Sik Kim; Asode Ananthram Shetty; Seok Jung Kim
Journal:  J Clin Orthop Trauma       Date:  2021-11-27

7.  Umbrella-shaped, memory alloy femoral head support device for treatment of avascular osteonecrosis of the femoral head.

Authors:  Xiaowei Yu; Wenxiong Jiang; Qi Pan; Tianyi Wu; Yan Zhang; Zubin Zhou; Dongpeng Du
Journal:  Int Orthop       Date:  2013-03-27       Impact factor: 3.075

8.  [Impacting bone graft via surgical hip dislocation approach versus core decompression and bone graft for avascular necrosis of femoral head at ARCO stage ].

Authors:  Haizhong Sun; Biaofang Wei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-05-15

9.  Outcome after a new porous tantalum rod implantation for treatment of early-stage femoral head osteonecrosis.

Authors:  Wei Huang; Xuan Gong; Steve Sandiford; Xiaoqiang He; Feilong Li; Yuwan Li; Ziming Liu; Leilei Qin; Jianye Yang; Sizheng Zhu; Jiawei Wang; Xiaolin Tu; Lei Ye; Ning Hu
Journal:  Ann Transl Med       Date:  2019-09

Review 10.  The Clinical Application of Porous Tantalum and Its New Development for Bone Tissue Engineering.

Authors:  Gan Huang; Shu-Ting Pan; Jia-Xuan Qiu
Journal:  Materials (Basel)       Date:  2021-05-18       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.